Skip to content

Valiant Navion™ VNMF4343C223TU (UDI 00763000100773)Recalls & reported problems

Medtronic, Inc. · STENT GRAFT VNMF4343C223TU VAL NAV FF · Class 3 · Implant

All models of Valiant Navion (137)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
1
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00763000100773), received between Jul 15, 2022 and Apr 1, 2025 — classified as 1 death, 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Detachment of Device or Device Component” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Detachment of Device or Device Component2
  • Leak/Splash2

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Aneurysm expansion1
  • Rupture1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 1, 2025Leak/Splash; Detachment of Device or Device Component; Leak/Splash; Detachment of Device or Device Component

    VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ANEURYSM. IT WAS REPORTED CORE LAB REVIEW OF CT IMAGING FROM APPROX. 48 MONTHS POST INDEX PROCEDURE, NOTED A NEW STENT RING ENLARGEMENT OF + 1.5MM WAS NOTED ON RING 4 OF (B)(6) AND +1.6MM ON RING 6 OF (B)(6). A NEW TYPE IIIB ENDOLEAK OBSERVED ON STENT GRAFT (B)(6). NO FRACTURE OR STENT RING MIGRATION WERE NOTED. THE MAXIMUM AORTIC DIAMETER MEASURED 58.5MM. NO AORTIC ENLARGEMENT WAS REPORTED. NO STENT RING MIGRATION OR STENT FRACTURES WERE OBSERVED. NO ADDITIONAL CLINICAL SEQUELAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.

    Patient problems: Aneurysm expansion; No Clinical Signs, Symptoms or Conditions

    MAUDE report 21738586 ↗
  • MalfunctionFeb 9, 2024Detachment of Device or Device Component; Detachment of Device or Device Component

    TWO VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A TYPE B AORTIC DISSECTION. THE PATIENT ALSO HAD A VALIANT CAPTIVIA AND NON MDT GRAFT IMPLANTED 2 YEARS POST THE INDEX PROCEDURE. IT WAS REPORTED CORE LAB REVIEW CT IMAGING FROM APPROXIMATELY 4 YEARS POST THE INDEX PROCEDURE SHOWED NEW STENT RING ENLARGEMENT OF +1.6MM, ON RING 3 OF VNMF4343C223TU. NO ENDOLEAK, STENT FRACTURE OR STENT RING MIGRATION WAS OBSERVED. THE MAX AORTIC DIAMETER WAS NOTED AS 53.5MM. NO AORTIC ENLARGEMENT WAS OBSERVED. THE CAUSE OF THE STENT RING ENLARGEMENT IS UNDETERMINED. NO ADDITIONAL SEQUELAE WERE REPORTED AND THE PATIENTS WILL BE MONITORED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18675430 ↗
  • DeathJul 15, 2022Leak/Splash; Leak/Splash

    VALIANT NAVION STENT GRAFTS WERE IMPLANTED FOR THE ENDOVASCULAR TREATMENT OF A 100MM THORACIC AORTIC ANEURYSM. ANOTHER VALIANT NAVION STENT GRAFT WAS IMPLANTED THE NEXT DAY. IT WAS REPORTED THE PATIENT PRESENTED EMERGENTLY APPROXIMATELY 11 MONTHS POST INDEX PROCEDURE WITH A THORACIC RUPTURE. THE PHYSICIAN STATED THE CT SHOWED A POSSIBLE TYPE III ENDOLEAK. THE PATIENT EXPIRED ON THE SAME DAY. AS PER THE PHYSICIAN THE CAUSE OF DEATH WAS AS A RESULT OF THE THORACIC RUPTURE. NO CAUSE OF THE ENDOLEAK HAS BEEN REPORTED. NO ADDITIONAL CLINICAL SEQUALAE WAS PROVIDED AND THE PATIENT HAS EXPIRED.

    Patient problems: Rupture

    MAUDE report 15026139 ↗

Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices

All SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page